NCT06290934: Study of GS-1427 in Participants With Moderately to Severely Active Ulcerative Colitis
- State
- Under way
- Phase
- Phase 2
- People
- 228 planned
- Started
- 27 Mar 2024
- Primary completion
- 4 Mar 2026
- Arms
- Part A, Part B, Part C: Emvistegrast Dose A, Part A, Part B, Part C: Emvistegrast Dose B, Part A, Part B, Part C: Emvistegrast Dose C
- Results
- None posted
- 4 Mar 2024: Trial registered
- 27 Mar 2024: Trial started